Short interest for Sharps Technology gives investors a sense of the degree to which investors are betting on the decline of Sharps Technology's stock. Short interest data is updated every two weeks.

Sharps Technology Stock (NASDAQ:STSS), Short Interest Report

Sharps Technology

Sharps Technology Inc is a medical device company. It offers syringes and other safety products. Sharps provensa, Securgard, and Sologard are ultra-low waste smart safety syringes are designed to eliminate potentially infectious and accidental needlestick injuries.

Long Ideas

News

Penny Stocks

Insider Trades

Markets

Trading Ideas

BTTR

RKDA

STSS

The Dow Jones index closed lower by more than 250 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company&#39;s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Better Choice Company And 2 Other Stocks Under $3 Insiders Are Buying

Small Cap

Intraday Update

Movers

AMAM

AMPE

ARBK

ARDX

AREN

Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share

AVDL

AXNX

BCRX

BFLY

BNZI

BSGM

CROX

CYCC

DADA

DVAX

ELEV

FSLY

HARP

LMDX

NEXI

NKTX

PACB

PRAX

PRTA

RGNX

RVNC

RXST

SHPH

SILK

SNMP

SPEC

STTK

TCJH

TREE

UPWK

VERO

VINC

ZJYL

Shares of  RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24 revenue guidance above estimates.

Also, Needham maintained a Buy rating on the stock and raised its price target from $35 to $41.

Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday&#39;s Mid-Day Session

Pre-Market Outlook

AIMD

BREA

CRGE

EFTR

FTFT

HRTX

HSCS

NSTG

VMAR

Shares of  LumiraDx Limited  (NASDAQ: LMDX) shares fell sharply in pre-market trading.

LumiraDx announced its securities will be suspended from trading on Nasdaq at the open of business on Jan. 9th.

LumiraDx shares dipped 30.5% to $0.0239 in pre-market trading.

Why LumiraDx Shares Are Trading Lower By Over 30%; Here Are 20 Stocks Moving Premarket

Sharps Technology Inc

Tesla and SpaceX CEO&nbsp;Elon Musk&nbsp;has expressed growing concern about the future of the U.S. dollar, citing the <a href="https://www.benzinga.com/general/24/03/37851477/u-s-national-debt-has-increased-by-nearly-8-5-billion-per-day-over-the-past-year">escalating national debt</a> as a potential catalyst for an impending economic crisis.
What Happened: On Friday, Musk was replying to a user on X, formerly Twitter, when he voiced his apprehensions about the U.S. dollar&#8217;s stability. &#8220;We need to do something&nbsp;about our national debt or&nbsp;the dollar will be worth&nbsp;nothing.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">We need to do something about our national debt or the dollar will be worth nothing
&mdash; Elon Musk (@elonmusk) <a href="https://twitter.com/elonmusk/status/1786365165463605754?ref_src=twsrc%5Etfw">May 3, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also:&nbsp;<a href="https://www.benzinga.com/news/24/05/38571981/ray-dalio-gives-a-nod-to-larry-summers-contention-that-federal-reserve-in-a-treacherous-environment?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Ray Dalio Gives A Nod To Larry Summer&#8217;s Contention That Federal Reserve In A &#8216;Treacherous Environment&#8217;: &#8216;Should Be Very Cautious About Possible Rate Cutting&#8217;</a>
He later reiterated his point, saying, &#8220;Just stating the obvious.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Just stating the obvious
&mdash; Elon Musk (@elonmusk) <a href="https://twitter.com/elonmusk/status/1786443824132169888?ref_src=twsrc%5Etfw">May 3, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Why It Matters: The U.S. national debt has been a subject of growing concern. In March, it was reported that the national debt had been increasing at an alarming rate of nearly $8.5 billion per day over the past year. As of May 2, the total <a href="https://fiscaldata.treasury.gov/datasets/debt-to-the-penny/debt-to-the-penny" target="_blank" rel="noreferrer noopener">national debt</a> stands at over $34 trillion.
Last month, the issue of the U.S. national debt&#8217;s sustainability was brought to the forefront by the International Monetary Fund or IMF deputy chief,&nbsp;Gita Gopinath, who stressed the <a href="https://www.benzinga.com/general/macro-notification/24/04/38337484/is-the-us-national-debt-unsustainable-we-cant-have-a-deficit-of-7-of-the-gdp">urgency of reducing the federal deficit</a> from its current 7% of GDP.
&#8220;The U.S. is running [a] very large deficit for a country with a strong demand, and they still have to deal with the last mile to bring inflation down,&#8221; Gopinath stated. 
Meanwhile, in an earlier post, Musk also suggested that&nbsp;<a href="https://www.benzinga.com/24/04/38223975/elon-musk-has-a-fix-for-ticking-us-debt-bomb-but-it-has-a-slight-chance-of-killing-us">AI could potentially solve the debt crisis</a>. &#8220;AI will solve this (slight chance of killing us),&#8221; he said in April. 
Read Next:&nbsp;<a href="https://www.benzinga.com/markets/equities/24/05/38563545/powell-keeps-hawks-at-bay-says-interest-rate-hike-unlikely-stocks-gold-rally-while-treasury-yiel?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Powell Keeps Hawks At Bay, Says Interest Rate Hike &#8216;Unlikely&#8217;: Stocks, Gold Rally, While Treasury Yields, Dollar Tumble</a>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Image via Shutterstock

Economics

Elon Musk Issues Stark Warning Amid Rising National Debt: '...The Dollar Will Be Worth Nothing'

Choosing what to watch this weekend after a grueling week can daunt even the most enthusiastic couch potatoes among us. But fret not, as the advent of May brings with it a fresh batch of releases from Netflix. The beloved streaming giant has rolled out a slew of new movies and some eagerly awaited series. From the comedic genius of Jerry Seinfeld to an intriguing Korean drama, there's a flavor for every taste bud.
Here are five handpicked TV shows and movies that you absolutely must carve out time for this weekend:
<h3 class="wp-block-heading">A Man in Full</h3>
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="576" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/03063844/A-man-in-full-1024x576.jpeg" alt="Although the tale is fictional, 'A Man in Full' mirrors the real-life trials faced by tycoons in similar scenarios. Image credit: Netflix/ Tudum" class="wp-image-321119" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/03063844/A-man-in-full-1024x576.jpeg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/03063844/A-man-in-full-300x169.jpeg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/03063844/A-man-in-full-768x432.jpeg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/03063844/A-man-in-full.jpeg 1280w" sizes="(max-width: 1024px) 100vw, 1024px" /><figcaption class="wp-element-caption">Although the tale is fictional, &#8216;A Man in Full&#8217; mirrors the real-life trials faced by tycoons in similar scenarios. Image credit: Netflix/ Tudum</figcaption></figure>
Immerse yourself in the tumultuous world of Charlie Croker, a real estate titan in Atlanta, as he faces the daunting prospect of bankruptcy and the potential ruin of his empire. Jeff Daniels breathes life into Croker in &#8220;A Man in Full,&#8221; a limited series inspired by Tom Wolfe's novel. While the story doesn't trace real events, it spins a narrative that mirrors the high-stakes challenges of industry moguls.
<h3 class="wp-block-heading">Unfrosted: The Pop-Tart Story</h3>
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="576" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/03064232/unfrosted-1024x576.jpeg" alt="Expect a mix of explosive corporate clashes and humorous twists, all delivered in Seinfeld's signature comedic style. Image credit: Netflix/ Tudum" class="wp-image-321141" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/03064232/unfrosted-1024x576.jpeg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/03064232/unfrosted-300x169.jpeg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/03064232/unfrosted-768x432.jpeg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/03064232/unfrosted.jpeg 1280w" sizes="(max-width: 1024px) 100vw, 1024px" /><figcaption class="wp-element-caption">Expect a mix of explosive corporate clashes and humorous twists, all delivered in Seinfeld&#8217;s signature comedic style. Image credit: Netflix/ Tudum</figcaption></figure>
Jerry Seinfeld makes his directorial debut with a dash of humor in &#8220;Unfrosted: The Pop-Tart Story,&#8221; where the breakfast staple is the unlikely hero. The film, starring Seinfeld alongside Melissa McCarthy and Hugh Grant, delves into the fierce rivalry between Kellogg&#8217;s and Post. Set in 1963, this comedic exploration follows their race to revolutionize breakfast, culminating in the creation of the beloved frosted pastry. Expect a mix of corporate intrigue and light-hearted comedy.
<h3 class="wp-block-heading">The Atypical Family</h3>
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="576" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/03064504/A-Atypical-Family-1024x576.jpeg" alt="&quot;The Atypical Family,&quot; an enchanting South Korean Netflix Original, blends romance with fantasy. Image credit: Netflix/ Tudum" class="wp-image-321147" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/03064504/A-Atypical-Family-1024x576.jpeg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/03064504/A-Atypical-Family-300x169.jpeg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/03064504/A-Atypical-Family-768x432.jpeg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/03064504/A-Atypical-Family.jpeg 1280w" sizes="(max-width: 1024px) 100vw, 1024px" /><figcaption class="wp-element-caption">&#8216;The Atypical Family&#8217; is an enchanting South Korean Netflix Original, that blends romance with fantasy. Image credit: Netflix/ Tudum</figcaption></figure>
From the creative minds of South Korea comes &#8220;The Atypical Family,&#8221; a romantic fantasy drama that explores the quirky Bok Gwi Doo and his family, all endowed with mysterious powers. When modern-day challenges strip them of their abilities, the arrival of Do Da He might just restore their lost magic. This series blends charm with the supernatural in a narrative that's both heartwarming and engaging.
<h3 class="wp-block-heading">The Peanut Butter Falcon</h3>
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="576" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/03070951/The-Peanut-Butter-Falcon-1024x576.jpg" alt="Zack Gottsagen, an actor with Down's syndrome, plays Zak in The Peanut Butter Falcon. Image credit: Netflix/ Tudum" class="wp-image-321191" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/03070951/The-Peanut-Butter-Falcon-1024x576.jpg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/03070951/The-Peanut-Butter-Falcon-300x169.jpg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/03070951/The-Peanut-Butter-Falcon-768x432.jpg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/03070951/The-Peanut-Butter-Falcon.jpg 1280w" sizes="(max-width: 1024px) 100vw, 1024px" /><figcaption class="wp-element-caption">Zack Gottsagen, an actor with Down's syndrome, plays Zak in The Peanut Butter Falcon. Image credit: Netflix/ Tudum</figcaption></figure>
Step into a heartening adventure with &#8220;The Peanut Butter Falcon,&#8221; a tale of friendship against the odds. This American comedy-drama follows a young man with Down syndrome who escapes from an assisted living facility and forms an unexpected bond with a fisherman on the lam. Starring Zack Gottsagen, Shia LaBeouf, and Dakota Johnson, the film is a testament to the unpredictable journeys that shape us.
<h3 class="wp-block-heading">Roast of Tom Brady</h3>
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="576" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/03071238/Greatest-Roast-of-all-time-tom-brady-1024x576.jpeg" alt="With Tom Brady at the center, nothing is off-limits in this laughter fest. Image credit: Netflix/ Tudum" class="wp-image-321196" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/03071238/Greatest-Roast-of-all-time-tom-brady-1024x576.jpeg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/03071238/Greatest-Roast-of-all-time-tom-brady-300x169.jpeg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/03071238/Greatest-Roast-of-all-time-tom-brady-768x432.jpeg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/03071238/Greatest-Roast-of-all-time-tom-brady.jpeg 1280w" sizes="(max-width: 1024px) 100vw, 1024px" /><figcaption class="wp-element-caption">With Tom Brady at the center, nothing is off-limits in this laughter fest. Image credit: Netflix/ Tudum</figcaption></figure>
Brace yourself for a laughter riot with the &#8220;Roast of Tom Brady,&#8221; part of Netflix's &#8220;Is a Joke Fest.&#8221; Hosted by Kevin Hart at the Kia Forum in Los Angeles, this event sees the seven-time Super Bowl champion as the good-natured target. With an array of comedians and sports legends lined up, including Jeff Ross and Rob Gronkowski, expect a barrage of jokes aimed at the unflappable Brady, who coolly claims he's &#8220;un-roastable.&#8221;
Photo via Shutterstock

Entertainment

General

Netflix And Chill: 5 Fresh Releases You Won't Want To Miss Watching This Weekend

BZFD

Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending

BZFDW

&nbsp;Vizsla Silver Corp. (TSXV:<a class="ticker" href="https://www.benzinga.com/stock/VZLA#TSXV">VZLA</a>) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VZLA#NYSE">VZLA</a>) (Frankfurt: 0G3) ("Vizsla Silver" or the "Company") is pleased to announce that it has now issued 448,137 common shares (the "Consideration Shares") for the previously announced asset purchase agreement (the "Acquisition Agreement") dated March 5, 2024, entered into with Inca Azteca Gold S.A.P.I. de C.V. (the "Seller") and the Company's wholly owned subsidiary, Minera Canam, S.A. de C.V. ("Minera Canam") pursuant to which the Company agreed to acquire, through Minera Canam, all of the Seller's right, title and interest in and to the mineral concessions (the "Acquisition").&nbsp;
The Company will acquire two large claims comprising 10,667.0 Ha (the "El Richard – San Enrique claims" or "San Enrique prospect") located south and partially adjacent to the Company's Panuco project (the "Panuco Project" or "Panuco").&nbsp; The San Enrique prospect is situated along the highly prospective Panuco – San Dimas corridor and is covered 100% with LiDAR and partially covered with high-resolution aero-magnetic and radiometric surveys.

TSXV:VZLA

VZLA

Vizsla Silver Provides Further Update On Acquisition Of Large Claim Package Along Highly Prospective Structural Trend, South Of Panuco

<a href="https://www.nytimes.com/2024/05/03/business/media/paramount-skydance-exclusive-talks-lapse.html#:~:text=Paramount's%20special%20committee%20is%20set,broadcast%20networks%2C%20like%20Paramount's%20CBS.">https://www.nytimes.com/2024/05/03/business/media/paramount-skydance-exclusive-talks-lapse.html#:~:text=Paramount's%20special%20committee%20is%20set,broadcast%20networks%2C%20like%20Paramount's%20CBS.</a>
&nbsp;
Paramount told Skydance that it would not extend the Hollywood studio's exclusive window to negotiate a merger, two people with knowledge of the decisions said Friday, imperiling the deal but opening the door to other suitors for the owner of MTV and Nickelodeon.
The development throws up a major roadblock for Skydance, a movie studio that has been negotiating a complicated deal to merge with Paramount for months. Many Paramount investors have come out against that deal, saying it would <a href="https://www.nytimes.com/2024/04/04/business/media/paramount-board-shari-redstone.html">enrich Shari Redstone</a>, the company's board chair, at the expense of other shareholders.
The 30-day period for exclusive talks with a special committee of Paramount's board expires at the end of Friday. It is unclear what Skydance, which was founded by the tech scion and producer David Ellison, and its backer, RedBird Capital Partners, will do next. The company could wait for Paramount to re-engage in negotiations, could make a higher bid or could walk away. The company is wary of being used by Paramount to drive up the price for another bidder.
Paramount's special committee will now probably focus on negotiating with another suitor, Sony Pictures Entertainment, which has teamed up with the private equity giant Apollo Global Management to make <a href="https://www.nytimes.com/2024/05/02/business/media/sony-apollo-paramount-deal.html">a $26 billion bid</a> for the company. Paramount's shareholders prefer the all-cash offer — which would include the assumption of Paramount's debt — because it would give them a substantial premium on the company's current stock price.
&nbsp;
Paramount's special committee is set to meet on Saturday to discuss the deal, the two people with knowledge of the company's plans said.
The deal with Sony and Apollo is not without its own risk. Government regulations restrict foreign ownership of broadcast networks, like Paramount's CBS. Sony Pictures Entertainment is a division of the Tokyo-based Sony Group, and it's unlikely that it could obtain a license to own CBS. But there are potential remedies to that problem: Apollo could apply to hold the license to CBS, or the group could decide to sell the network.
Paramount's fate ultimately lies in Ms. Redstone's hands. Her control of National Amusements, Paramount's parent company, gives her the power to block any deal. Ms. Redstone has already signed off on a potential deal between Skydance and National Amusements that would allow her to sell her stake for around $2 billion, but that deal hinges on approval of a merger of Paramount and Skydance.
CNBC earlier <a href="https://www.cnbc.com/2024/05/03/paramount-news-skydance-could-drop-bid-after-sony-apollo-offer.html">reported</a> that Paramount was planning to end exclusive negotiations with Skydance.

PARA

PARAA

"Paramount Will Let Exclusive Talks With Skydance Lapse, Imperiling Deal; Negotiations Are Now Likely To Focus On Another Suitor, Sony, Which Has Teamed Up With The Private Equity Giant Apollo On A $26B Bid" - NY Times

Earnings

HCWB

HCW Biologics Says Due To Default Issue, Concluded Financial Statements As Of & For Year Ended Dec 31, 2023 Should Be Restated & No Longer Be Relied Upon

Contracts

On May 1, Eagle Materials Inc TLCC Partners, HM, HMSC Entered Into A Put Option Agreement; Under Agreement, TLCC Partners Granted Put Option To HMSC; Put Option Entitles HMSC To Require TLCC Partners To Purchase All Partnership Interests Held By HMSC In JV; Under Put Option, TLCC Partners To Buy All Partnership Interests Of HMSC In JV For Payment Of Amount Equal To 50% Of $1.1B

Growing wealth is not as difficult as it seems, according to a self-made millionaire Ramit Sethi. It's easy enough that Sethi thinks it takes only three "deceptively" simple steps to accumulate wealth and gain financial independence.
Sethi is the author of the book "I Will Teach You To Be Rich" which outlines a six-week process to help readers choose the right investments to make sure their money grows.
Whether you're worried about your home loans, student loans, or any other debt, or if it's about asking for that big raise you've been eyeing, Sethi has a strategy for you.
Sethi revealed three "boring" and "deceptively" simple steps to grow wealth, in an earlier interview <a href="https://www.cnbc.com/2023/07/07/self-made-millionaire-ramit-sethi-no-1-way-to-grow-your-wealth.html">with</a> CNBC.
<h2 class="wp-block-heading">Three Steps To Grow Your Wealth</h2>
<h3 class="wp-block-heading">1. Start Investing And Increase It Steadily</h3>
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="576" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/03083837/Wealth-1-1024x576.jpg" alt="" class="wp-image-321378" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/03083837/Wealth-1-1024x576.jpg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/03083837/Wealth-1-300x169.jpg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/03083837/Wealth-1-768x432.jpg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/03083837/Wealth-1-1536x864.jpg 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/03083837/Wealth-1.jpg 1920w" sizes="(max-width: 1024px) 100vw, 1024px" /><figcaption class="wp-element-caption">Representational image of a person investing &#x7C; Photo courtesy: Dall-E</figcaption></figure>
The first step to becoming wealthy is to start investing. It's a habit and once formed, you can set it on autopilot and let the money grow itself.
"Invest a percentage of your income every year automatically and increase that percentage 1%."
Suppose you're wondering whether your investments can perform as well as those of rich people who have access to options that regular people don't. In that case, Sethi says they "typically do not perform better than a simple S&amp;P index fund."
Identify a simple low-cost index fund and get going.
<h3 class="wp-block-heading">2. Ask For The Salary You Want And Deserve</h3>
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="576" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/03084055/Wealth-2-1-1024x576.jpg" alt="" class="wp-image-321383" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/03084055/Wealth-2-1-1024x576.jpg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/03084055/Wealth-2-1-300x169.jpg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/03084055/Wealth-2-1-768x432.jpg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/03084055/Wealth-2-1-1536x864.jpg 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/03084055/Wealth-2-1.jpg 1920w" sizes="(max-width: 1024px) 100vw, 1024px" /><figcaption class="wp-element-caption">Representational image of two people in an office &#x7C; Photo courtesy: Shutterstock</figcaption></figure>
Investing is one side of the wealth journey. Making sure you're able to invest consistently is the other aspect. For most people, the source is salary, and making sure you're getting the right salary is important.
"Learn the skills of negotiating your salary and getting paid what you're worth," says Sethi.
One good way to make sure you're getting paid right is by checking what others in the same position as you are being paid.
<h3 class="wp-block-heading">3. Develop A Side Hustle</h3>
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="576" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/03084119/Wealth-3-1024x576.jpg" alt="" class="wp-image-321384" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/03084119/Wealth-3-1024x576.jpg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/03084119/Wealth-3-300x169.jpg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/03084119/Wealth-3-768x432.jpg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/03084119/Wealth-3-1536x864.jpg 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/03084119/Wealth-3.jpg 1920w" sizes="(max-width: 1024px) 100vw, 1024px" /><figcaption class="wp-element-caption">Representational image of a person working &#x7C; Photo courtesy: Dall-E</figcaption></figure>
While not everyone is a fan of hustling, the journey to making wealth requires you to put in that extra effort.
"If you really want to increase your earnings, consider starting a business on the side," suggests Sethi.
This hustle could be anything you like – the only idea is that you get more money out of it than you put in. It can even be a hobby, provided it can be made profitable.
Image from Shutterstock

Personal Finance

'I Will Teach You To Be Rich' Author, Ramit Sethi, Became A Self-Made Millionaire — He Now Shares His Simple Formula To Grow Your Wealth

In Q1, Citigroup Got Notification From FDIC That FDIC Special Assessment Estimate To Increase To $20.4B; In Q1, Increased Its Total Accrued Estimated Liability To $2B For The FDIC Special Assessment

CLIR

On May 2, Clearsign Technologies Received Letter From Nasdaq That Company No Longer Meets The Minimum Bid Price Requirement

ADTN

Adtran Impairment Assessment Was Triggered As A Result Of Factors Such As A Decrease In Co's Market Capitalization; Impairment Assessment Was Triggered As A Result Of Factors Such As Cautious Service Provider Spending Due To Economic Uncertainty

Adtran Determined That A Material Charge For Impairment To Goodwill Will Be Required For Q1 Of 2024; Impairment Leads To An Increased GAAP Operating Loss For Q1 2024 By Same Amount; Charge Has No Impact On Co's Compliance With Covenants Under Its Credit Agreement; Non-Cash Goodwill Impairment On Carrying Amount Of Goodwill Solely Allocated To Network Solutions Segment Estimated Around $293M

AAON

MARA

S&P Dow Jones Indices Says Marathon Digital Holdings Inc. Will Replace AAON In The S&P Smallcap 600 Effective Prior To The Market Open On May 8

S&P Dow Jones Indices Says AAON Inc. Will Replace Vistra In The S&P Midcap 400 Effective Prior To The Market Open On May 8

S&P Dow Jones Indices Says Vistra Corp. Will Replace Pioneer Natural Resources Co. In The S&P 500 Effective Prior To The Market Open On May 8

QDRO

Quadro Acquisition One Provided Notice To NHC Holdings II That It Has Terminated Business Combination Agreement

IPOs

Zeekr Intelligent Technology Holding Ltd Sees IPO Price In Range Of $18-$21/ADS; Existing Shareholders, Third-Party Investors Indicated To Subscribe Up To $349.1M Of ADSs Being Offered In IPO; Sees U.S. Ipo Of 17.5M ADSs; Plans To Use About $138.9MOf IPO Proceeds, To Develop More Advanced Bev Technologies, Expansion Of Product Portfolio; Plans To Use About $138.9M, For Selling, Marketing, Expansion Of Service And Charging Network

Offerings

LAZR

Luminar Files For Mixed Shelf; Size Not Disclosed

SOFI, OKE and INTU among pre-market losers

Sharp Technology acquires syringe manufacturing facility, signs 10-year $400M purchase agreement

Sharps Technology announces $5.6M registered direct and private placement

Sharps Technology to sell 11.33M shares for holders

Sharps Technology director Timothy Ruemler buys 15K common shares

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are a hot topic this morning as we cover all of the biggest market news traders need to know about on Thursday!



Moving stocks this morning are a research agreement, delisting notice, proposed public offering and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Jeffs Brands (NASDAQ:<a href="https://investorplace.com/stock-quotes/jfbr-stock-quote/">JFBR</a>) stock is rocketing more than 78% alongside heavy pre-market trading on Thursday.</li>



<li>Omega Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/omga-stock-quote/">OMGA</a>) shares are soaring over 56% after <a href="https://www.nasdaq.com/press-release/novo-nordisk-enters-into-research-collaborations-with-omega-therapeutics-and">entering into a research collaboration agreement</a> with Novo Nordisk (NYSE:<a href="https://investorplace.com/stock-quotes/nvo-stock-quote/">NVO</a>).</li>



<li>180 Life Sciences (NASDAQ:<a href="https://investorplace.com/stock-quotes/atnf-stock-quote/">ATNF</a>) stock is surging close to 44% with strong early morning trading.</li>



<li>Arena Group (NYSEMKT:<a href="https://investorplace.com/stock-quotes/aren-stock-quote/">AREN</a>) shares are gaining more than 25% as it also sees heavy trading on Thursday.</li>



<li>ATIF (NASDAQ:<a href="https://investorplace.com/stock-quotes/atif-stock-quote/">ATIF</a>) stock is increasing over 24% without any clear news this morning.</li>



<li>Kintara Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/ktra-stock-quote/">KTRA</a>) shares are rising more than 22% with extremely heavy trading this morning.</li>



<li>Faraday Future (NASDAQ:<a href="https://investorplace.com/stock-quotes/ffie-stock-quote/">FFIE</a>) stock is climbing over 15% despite <a href="https://electrek.co/2024/01/04/faraday-delivers-its-300k-luxury-ev-but-its-stock-is-plummeting/">a delisting warning</a>.</li>



<li>Ampio Pharmaceuticals (NYSEMKT:<a href="https://investorplace.com/stock-quotes/ampe-stock-quote/">AMPE</a>) shares are heading more than 11% higher today.</li>



<li>LeddarTech (NASDAQ:<a href="https://investorplace.com/stock-quotes/ldtc-stock-quote/">LDTC</a>) stock is jumping over 11% after <a href="https://www.nasdaq.com/press-release/leddartech-appoints-oren-dayan-as-vice-president-of-product-line-management-and">appointing a new executive</a>.</li>



<li>Warrantee (NASDAQ:<a href="https://investorplace.com/stock-quotes/wrnt-stock-quote/">WRNT</a>) shares are up more than 9% on Thursday morning.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Bank of Montreal MicroSectors Travel -3x Inverse Leveraged ETN (NYSEARCA:<a href="https://investorplace.com/stock-quotes/flyd-stock-quote/">FLYD</a>) is crashing over 55% without any obvious news.</li>



<li>SELLAS Life Sciences (NASDAQ:<a href="https://investorplace.com/stock-quotes/sls-stock-quote/">SLS</a>) shares are plummeting 32% alongside a <a href="https://www.nasdaq.com/press-release/sellas-life-sciences-announces-proposed-public-offering-2024-01-03">proposed public offering</a>.</li>



<li>Sharps Technology (NASDAQ:<a href="https://investorplace.com/stock-quotes/stss-stock-quote/">STSS</a>) stock is diving nearly 20% on Thursday. </li>



<li>Airship AI (NASDAQ:<a href="https://investorplace.com/stock-quotes/aisp-stock-quote/">AISP</a>) shares are tumbling more than 15% after <a href="https://www.nasdaq.com/press-release/airship-ai-makes-its-debut-on-the-nasdaq-after-completing-merger-with-byte">going public last week</a>.</li>



<li>Hallmark Financial Services (NASDAQ:<a href="https://investorplace.com/stock-quotes/hall-stock-quote/">HALL</a>) stock is dropping over 15% without any obvious news.</li>



<li>RiskOn International (NASDAQ:<a href="https://investorplace.com/stock-quotes/roi-stock-quote/">ROI</a>) shares are decreasing almost 15% despite announcing a <a href="https://www.nasdaq.com/press-release/riskon-international-and-meetkai-unveil-generative-ai-platform-askroi-and-announce">generative artificial intelligence (AI) program yesterday</a>.</li>



<li>ABVC BioPharma (NASDAQ:<a href="https://investorplace.com/stock-quotes/abvc-stock-quote/">ABVC</a>) stock is falling more than 14% after rallying on <a href="https://www.globenewswire.com/news-release/2024/01/03/2803186/0/en/ABVC-BioPharma-and-its-Subsidiary-Receive-460M-From-AiBtl-BioPharma-as-the-First-Milestone-Payment-of-Global-Licensing-Fees.html">a funding announcement</a> yesterday.</li>



<li>Brera (NASDAQ:<a href="https://investorplace.com/stock-quotes/brea-stock-quote/">BREA</a>) shares are slipping close to 13% on Thursday morning.</li>



<li>Lytus Technologies (NASDAQ:<a href="https://investorplace.com/stock-quotes/lyt-stock-quote/">LYT</a>) stock is dipping over 10% today.</li>



<li>Evotec (NASDAQ:<a href="https://investorplace.com/stock-quotes/evo-stock-quote/">EVO</a>) shares close out our pre-market stock movers down more than 10% with <a href="https://www.bloomberg.com/news/articles/2024-01-04/evotec-shares-plunge-after-ceo-lanthaler-unexpectedly-steps-down?embedded-checkout=true">the resignation of its CEO</a>.</li>
</ol>On the date of publication, William White&nbsp;did not have (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/05/secret-income-blueprint-of-the-one-percent/?cid=MKT730394&amp;eid=MKT771243">The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/01/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-thursday-jan-4th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
It&rsquo;s time to start the week with a breakdown of the biggest pre-market stock movers worth keeping an eye on for Monday!



Moving stocks this morning are buyout rumors, clinical trial data, a stock suspension date and more.



Let&rsquo;s get into this news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Harpoon Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/harp-stock-quote/">HARP</a>) stock is rocketing more than 105% on reports that Merck (NYSE:<a href="https://investorplace.com/stock-quotes/mrk-stock-quote/">MRK</a>) <a href="https://www.reuters.com/business/healthcare-pharmaceuticals/merck-talks-buy-harpoon-therapeutics-around-700-mln-bloomberg-news-2024-01-08/">wants to buy the company</a>.</li>



<li>Cellectar Biosciences (NASDAQ:<a href="https://investorplace.com/stock-quotes/clrb-stock-quote/">CLRB</a>) shares are soaring over 56% alongside <a href="https://www.nasdaq.com/press-release/cellectar-biosciences-announces-positive-topline-data-achieving-primary-endpoint-in">positive clinical trial data</a>.</li>



<li>Spectaire (NASDAQ:<a href="https://investorplace.com/stock-quotes/spec-stock-quote/">SPEC</a>) stock is surging close to 56% with heavy early morning trading.</li>



<li>Vincerx Pharma (NASDAQ:<a href="https://investorplace.com/stock-quotes/vinc-stock-quote/">VINC</a>) shares are gaining more than 48% after <a href="https://www.marketwatch.com/story/vincerx-pharma-shares-surge-following-early-results-for-relapsed-refractory-lymphoma-d88c6618">publising early study results</a>.</li>



<li>Cyclacel Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/cycc-stock-quote/">CYCC</a>) stock is rising over 32% <a href="https://www.nasdaq.com/press-release/cyclacel-pharmaceuticals-to-present-at-biotech-showcase-2024-2024-01-02">ahead of a presentation today</a>.</li>



<li>Lixiang Education (NASDAQ:<a href="https://investorplace.com/stock-quotes/lxeh-stock-quote/">LXEH</a>) shares are increasing more than 18% without any clear news this mroning.</li>



<li>Heron Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/hrtx-stock-quote/">HRTX</a>) stock is climbing over 18% after <a href="https://www.marketwatch.com/story/heron-therapeutics-shares-rise-17-after-zynrelef-distribution-partnership-c1975759?mod=markets">announcing a new distribution partnership</a>.</li>



<li>Brooge Energy (NASDAQ:<a href="https://investorplace.com/stock-quotes/brog-stock-quote/">BROG</a>) shares are heading more than 14% higher on Monday morning.</li>



<li>LQR House (NASDAQ:<a href="https://investorplace.com/stock-quotes/lqr-stock-quote/">LQR</a>) stock is jumping over 13% today.</li>



<li>Alaunos Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/tcrt-stock-quote/">TCRT</a>) shares are up more than 13% on Monday.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>LumiraDx (NASDAQ:<a href="https://investorplace.com/stock-quotes/lmdx-stock-quote/">LMDX</a>) stock is plummeting over 28% ahead of its <a href="https://www.nasdaq.com/press-release/lumiradx-announces-its-securities-will-be-suspended-from-trading-on-nasdaq-at-the">securities being suspended tomorrow</a>.</li>



<li>Spirit AeroSystems (NYSE:<a href="https://investorplace.com/stock-quotes/spr-stock-quote/">SPR</a>) shares are diving more than 19% following <a href="https://seekingalpha.com/news/4052850-shares-of-boeing-and-spirit-aerosystems-plunge-after-mid-air-blowout">a mid-air blowout</a>.</li>



<li>Banzai International (NASDAQ:<a href="https://investorplace.com/stock-quotes/bnzi-stock-quote/">BNZI</a>) stock is tumbling over 17% on Monday morning. </li>



<li>Arena (NYSEMKT:<a href="https://investorplace.com/stock-quotes/aren-stock-quote/">AREN</a>) shares are taking a more than 17% beating <a href="https://www.marketwatch.com/story/arena-group-shares-tumble-after-interim-ceo-of-sports-illustrated-parent-company-steps-down-6e9966bb">as its interim CEO steps down</a>.</li>



<li>Safe &amp; Green Development (NASDAQ:<a href="https://investorplace.com/stock-quotes/sgd-stock-quote/">SGD</a>) stock is sliding over 15% following a Friday rally.</li>



<li>Inspire Veterinary (NASDAQ:<a href="https://investorplace.com/stock-quotes/ivp-stock-quote/">IVP</a>) shares are falling more than 13% this morning.</li>



<li>Future FinTech (NASDAQ:<a href="https://investorplace.com/stock-quotes/ftft-stock-quote/">FTFT</a>) stock is dropping over 13% today.</li>



<li>Sharps Technology (NASDAQ:<a href="https://investorplace.com/stock-quotes/stss-stock-quote/">STSS</a>) shares are slipping more than 13% on Monday morning.</li>



<li>Ainos (NASDAQ:<a href="https://investorplace.com/stock-quotes/aimd-stock-quote/">AIMD</a>) stock is dipping over 11% <a href="https://investorplace.com/2024/01/why-is-ainos-aimd-stock-up-157-today/">after a recent rally</a>.</li>



<li>Multi Ways (NYSEMKT:<a href="https://investorplace.com/stock-quotes/mwg-stock-quote/">MWG</a>) shares close out our pre-market stock movers down nearly 11%.</li>
</ol><ol><li>
</ol>On the date of publication, William White&nbsp;did not have (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/07/venture-capitalist-predicts-this-chatgpt-announcement-will-shock-the-world/?cid=MKT744191&amp;eid=MKT766413">ChatGPT IPO Could Shock the World, Make This Move Before the Announcement</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/05/secret-income-blueprint-of-the-one-percent/?cid=MKT730394&amp;eid=MKT766529">The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/01/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-monday-jan-8th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

Sharps Technology signs sales and distribution agreement with Roncadelle Operations

Sharps Technology, Inc. (STSS) has issued an announcement. Sharps Technology, Inc. has announced a new development through a press release on March...

Sharps Technology Announces Key Regulatory Disclosure

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Sharps Technology (NASDAQ:<a href="https://investorplace.com/stock-quotes/stss-stock-quote/">STSS</a>) just reported results for the fourth quarter of 2023.<ul><li>Sharps Technology reported earnings per share of -17 cents.</li><li>The company did not report any revenue for the quarter.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/04/stss-stock-earnings-sharps-technology-for-q4-of-2023/">STSS Stock Earnings: Sharps Technology Reported Results for Q4 2023</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

STSS Stock Earnings: Sharps Technology Reported Results for Q4 2023

ABVC

AISP

ATIF

ATNF

BROG

CDIO

CLRB

DRMA

FFIE

FLYD

GSIT

HALL

HEPS

HOUR

INTU

JFBR

KTRA

LDTC

LRMR

LXEH

MEGL

MHUA

OMGA

SOFI

TCRT

TTCF

WRNT

XELA

ZAPP

Press Releases

Sharps Technology, Reviva Pharmaceuticals, and American Resources Corp. Interviews to Air on the RedChip Money Report(R) on Bloomberg TV

Financing

Sharps Technology Announces Closing of $5.6 Million Registered Direct and Private Placement

Aegis Capital Corp. Acted as Exclusive Placement Agent on a $5.6 Million Registered Direct & Private Placement Priced at the Market Under Nasdaq Rules for Sharps Technology, Inc. (NASDAQ: STSS)

Sharps Technology (STSS) To Enter The Copolymer Prefillable Syringe Market With Strength And Ahead of Plan Through Pending Manufacturing Facility Acquisition and $400M Nephron Deal

Pending $400 Million Purchase Agreement To Advance Sharps Into Large Prefillable Syringe Market With Differentiated Copolymer Syringe Systems

Sharps Technology Signs LOI with Roncadelle Operations Intended to Open Worldwide Sales and Distribution Opportunities for Safe Drug Delivery Systems

Sharps Technology Planning To Collaborate With Roncadelle To Support Global Distribution And Sales Of High Quality, Innovative, Safer Drug Delivery Systems

Sharps Technology Enters Latin American Market and Receives First Orders for Securegard Disposable Smart Safety Syringes from Strategic Distribution Partner in Colombia

Sharps Technology and Roncadelle Operations Sign Worldwide Sales and Distribution Agreement for their Innovative Portfolio of Safe Technology Drug Delivery Systems

Sharps Technology's Global Expansion: Achieving Key Milestones To Strengthen Market Position

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Sharps Technology Stock (NASDAQ:STSS), Short Interest Report

People Also Watch